Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma (Q41183377)
Jump to navigation
Jump to search
scientific article published on 26 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma |
scientific article published on 26 October 2015 |
Statements
1 reference
Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA-122 levels without affecting other microRNAs in plasma (English)
1 reference
M H van der Ree
1 reference
A J van der Meer
1 reference
A C van Nuenen
1 reference
J de Bruijne
1 reference
S Ottosen
1 reference
H L Janssen
1 reference
N A Kootstra
1 reference
H W Reesink
1 reference
26 October 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference